Cetera Trust Company N.A trimmed its stake in Koninklijke Philips (NYSE:PHG – Free Report) by 8.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 9,609 shares of the technology company’s stock after selling 939 shares during the period. Cetera Trust Company N.A’s holdings in Koninklijke Philips were worth $243,000 as of its most recent SEC filing.
A number of other large investors have also recently bought and sold shares of PHG. Wilmington Savings Fund Society FSB bought a new stake in shares of Koninklijke Philips in the 3rd quarter worth about $54,000. Eastern Bank bought a new stake in Koninklijke Philips during the third quarter worth about $88,000. RPg Family Wealth Advisory LLC bought a new stake in Koninklijke Philips during the third quarter worth about $107,000. Clifford Capital Partners LLC bought a new stake in Koninklijke Philips during the 2nd quarter worth approximately $201,000. Finally, OLD National Bancorp IN bought a new stake in Koninklijke Philips during the 3rd quarter worth approximately $202,000. 13.67% of the stock is currently owned by institutional investors.
Koninklijke Philips Price Performance
Shares of PHG stock opened at $26.67 on Wednesday. The firm has a market cap of $25.07 billion, a price-to-earnings ratio of -63.54, a PEG ratio of 0.86 and a beta of 0.77. Koninklijke Philips has a 12 month low of $19.55 and a 12 month high of $32.91. The company has a quick ratio of 0.74, a current ratio of 1.16 and a debt-to-equity ratio of 0.60. The stock has a 50-day moving average price of $25.85 and a 200 day moving average price of $28.08.
Analysts Set New Price Targets
Read Our Latest Research Report on Koninklijke Philips
Koninklijke Philips Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Stories
- Five stocks we like better than Koninklijke Philips
- How to Invest in Blue Chip Stocks
- Tempus AI: A Game-Changer in AI-Powered Healthcare
- Comparing and Trading High PE Ratio Stocks
- Pelosi Bets Big on AI: This Is What You Need to Know
- There Are Different Types of Stock To Invest In
- Mobileye’s High Short Interest Signals Squeeze Potential
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.